How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 12, 2000, Pages 4562-4567

  L'Allemand, D ^a   Tardy, V ^b   Gruters A ^a   Schnabel, D ^a   Krude, H ^a   Morel, Y ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; HYDROXYPROGESTERONE; STEROID 21 MONOOXYGENASE;

ARTICLE; CLINICAL EXAMINATION; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; DISEASE CLASSIFICATION; EXON; FEMALE; GENE DELETION; GENETIC CODE; GENETIC TRANSCRIPTION; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HYBRID GENE; MOLECULAR WEIGHT; NEWBORN; NEWBORN SCREENING; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PSEUDOGENE; STEROID 21 MONOOXYGENASE DEFICIENCY; VIRILIZATION;

EID: 0034486847     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.12.4562     Document Type: Article

References (35)

1. Diagnosis and management of congenital adrenal hyperplasia
2. Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
3. Characterization of frequent deletions causing steroid 21-hydroxylase deficiency
4. Molecular pathology of congenital adrenal hyperplasia
5. Mutations in steroid 21-hydroxylase (CYP21)
6. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency
7. Molecular genetics of 21-hydroxylase deficient adrenal hyperplasia
8. An update on the molecular genetics of congenital adrenal hyperplasia: Diagnostic and therapeutic aspects
9. Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency
10. Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase
11. Steroid 21-hydroxylase deficiency; genotype may not predict phenotype
12. Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations
13. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
14. Molecular basis of nonclassical steroid 21-hydroxylase deficiency detected by neonatal mass screening in Japan
15. Dépistage de l'hyperplasie surrénale congénitale par déficit en 21-hydroxylase; expérience de l'association française pour le dépistage et la prévention des handicaps de l'erffant
16. Nonclassical adrenal hyperplasia due to 21-hydroxylase-deficiency; does genotyping predict the clinical manifestation
17. Results of screening 1.9 million Texas newborns for 21-hydroxylase- deficient congenital adrenal hyperplasia
18. Rearrangements and point mutations of P450c21 genes are distinguished by five restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adrenal hyperplasia
19. Improving the efficacy of a newborn screening for congenital hypothyroidism by adjusting the cut-off level of 17-hydroxyprogesterone to gestational age
20. Genotype-phenotype analysis in late onset 21-hydroxylase deficiency in comparison to the classic forms
21. Dihydrospirorenone, a new progestogen with antimineralocorticoid activity; effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women
22. Longitudinal studies of plasma aldosterone, corticosterone, deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone determined simultaneously in mother and child at birth and during the early neonatal period. I. Spontaneous delivery
23. Plasma aldosterone and 11-deoxycortisol in term neonates; a reevaluation
24. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: A pseudogene and a genuine gene
25. Isolated aldosterone synthase deficiency caused by simultaneous E198D and V386A mutations in the CYP11B2 gene
26. Two distinct areas of unequal crossing-over within the steroid 21-hydroxylase genes produce absence of CYP21B
27. Identification of the recombination site within the steroid 21-hydroxylase gene (CYP21) of the HLA-B47,DR7 haplotype
28. The HLA-A3,Cw6,B47,DR7 extended haplotypes in salt losing 21-hydroxylase deficiency and in the Old Order Amish: Identical class I antigens and class II alleles with at least two cross-over sites in the class III region
29. Abundant adrenal-specific transcription of the human P450c21A pseudogene
30. Difference in transcriptional activity of two homologous CYP21A genes
31. A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele
32. Mutations of P450c21 (steroid-21-hydroxylase) at Cys428, Va1281, and Ser268 result in complete, partial, or no loss of enzymatic activity, respectively
33. Prenatal treatment of congenital hyperplasia
34. Prenatal treatment of congenital hyperplasia: A commentary
35. Prenatal treatment of congenital hyperplasia: A promising experimental therapy of unproven safety